Sign Up to like & get
recommendations!
1
Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13154
Abstract: Treatment of non‐IgM type I cryoglobulinaemic vasculitis (CV) is challenging. Corticosteroids are first‐line therapy, but relapses are frequent leading to therapeutic escalation. Bortezomib is a proteasome inhibitor with rapid effect on monoclonal component. However, its…
read more here.
Keywords:
cryoglobulinaemic vasculitis;
non igm;
type cryoglobulinaemic;
igm type ... See more keywords